Citations

Clear

4847 citation(s) found for "Tu, Eric".

Pharmacogenomic findings from clinical whole exome sequencing of diagnostic odyssey patients
Cousin, Margot A. , Matey, Eric T. , Blackburn, Patrick R. , Boczek, Nicole J. , McAllister, Tammy M., Kruisselbrink, Teresa , Babovic‐Vuksanovic, Dusica , Klee, Eric W. , Kruisselbrink, Teresa M, Lazaridis, Konstantinos N. , Cousin, Margot A

Mayo Clinic

Molecular Genetics & Genomic Medicine | March 20, 2017 | Volume: 5 | Issue: 3 | Pages: 269-279

10.1002/mgg3.283 | PMID 28546997 Get It

AbstractBackgroundWe characterized the pharmacogenomics (PGx) results received by diagnostic odyssey patients as secondary findings during clinical whole exome sequencing (WES) testing as a part of their care in Mayo Clinic's Individualized Medicine Clinic to determine the potential benefits and limitations to this cohort.MethodsWES results on 94 patients included a subset of PGx variants in CYP2C19, CYP2C9, and VKORC1 if identified in the patient. Demographic, phenotypic, and medication usage information was abstracted from patient medical data. A pharmacist interpreted the PGx results in the context of the patients’ current medication use and made therapeutic recommendations.ResultsThe majority was young with a median age of 10 years old, had neurological involvement in the disease presentation (71%), and was currently taking medications (90%). Of the 94 PGx‐evaluated patients, 91% had at least one variant allele reported and 20% had potential immediate implications on current medication use.ConclusionDue to the disease complexity and medication needs of diagnostic odyssey patients, there may be immediate benefit obtained from early life PGx testing for many and most will likely find benefit in the future. These results require conscientious interpretation and management to be actionable for all prescribing physicians throughout the lifetime of the patient.
Sex differences in utilization and outcomes of catheter-directed thrombolysis in patients with proximal lower extremity deep venous thrombosis – Insights from the Nationwide Inpatient Sample
Lakhter, Vladimir , Zack, Chad, Brailovsky, Yevgeniy , Aggarwal, Vikas , Rao, Koneti A., Crabbe, Deborah L. , Choi, Eric T., Bashir, Riyaz , Zack, Chad J, Chatterjee, Saurav , Zhao, Huaqing , Kolluri, Raghu , Brailovsky, Yevgeniy

Mayo Clinic

Vascular Medicine | March 17, 2017 | Volume: 22 | Issue: 2 | Pages: 128-134

10.1177/1358863x17694091 | PMID 28429658 Get It

Catheter-directed thrombolysis (CDT) is being increasingly used for the treatment of proximal lower extremity (LE) deep venous thrombosis (DVT). However, sex differences in utilization and safety outcomes of CDT in these patients are unknown. The Nationwide Inpatient Sample (NIS) database was used to identify all patients with a principal discharge diagnosis of proximal LE or caval DVT who underwent CDT between January 2005 and December 2011 in the United States. We evaluated the comparative safety outcomes of CDT among a propensity-matched group of 1731 men versus 1731 women. Among 108,243 patients with proximal LE or caval DVT, 4826 patients (4.5%) underwent CDT. Overall, women underwent CDT less often compared to men (4.1% vs 4.9%, p<0.01, respectively). The rates of CDT increased between 2005 and 2011 for both women (2.1% to 5.9%, p<0.01) and men (2.5% to 7.5%, p<0.01). There was no significant difference in in-hospital mortality (1.2% vs 1.3%, p=0.76). Women were noted to have higher rates of blood transfusions (11.7% vs 8.8%, p<0.01), but lower rates of intracranial hemorrhage (0.5% vs 1.2%, p=0.03) and gastrointestinal bleeding (0.9% vs 2.2%, p<0.01) compared with men. Women were more likely to undergo inferior vena cava filter placement (37.0% vs 32.1%, p<0.01). In this large nationwide cohort, women with proximal DVT were less likely to receive CDT compared to men. Although mortality rates were similar, women were noted to have higher blood transfusion rates while men had more episodes of intracranial and gastrointestinal bleeding.
Comparative analysis of de novo assemblers for variation discovery in personal genomes
Tian, Shulan , Yan, Huihuang , Klee, Eric W. , Kalmbach, Michael T., Kalmbach, Michael, Slager, Susan L.

Mayo Clinic

Briefings in Bioinformatics | March 16, 2017 | Volume: 19 | Issue: 5 | Pages: 893-904

10.1093/bib/bbx037 | PMID 28407084 Get It

Assessment of cardiac allograft systolic function by global longitudinal strain: From donor to recipient
DeVore, Adam D. , Alenezi, Fawaz , Krishnamoorthy, Arun, Ersbøll, Mads , Samsky, Marc D. , Schulte, Phillip J. , Patel, Chetan B. , Rogers, Joseph G. , Milano, Carmelo A. , Khouri, Michel G. , Velazquez, Eric J.

Mayo Clinic

Clinical Transplantation | March 15, 2017 | Volume: 31 | Issue: 5 | Pages: e12961

10.1111/ctr.12961 | PMID 28294407 Get It

Giant Cell Tumor of the Metacarpal: Case Report
Lewallen, Laura, Wagner, Eric R. , Moran, Steven L. , Lewallen, Laura W, Wagner, Eric R

Mayo Clinic

HAND | March 7, 2017 | Volume: 12 | Issue: 5 | Pages: NP113-NP117

10.1177/1558944717697431 | PMID 28719994 Get It

Background: Giant cell tumor (GCT) of bone is a benign, though locally aggressive tumor, classically described as an eccentric lytic lesion, often with cortical expansion and destruction. It typically involves the metaphysis or epiphysis of long bones in skeletally mature patients, with a slight female predominance. The incidence in the small bones of the hand has been reported to be 2% to 5%. Methods: Treatment options have evolved in recent years, and currently include intralesional curettage with or without adjuvant therapy, wide resection, and occasionally amputation. Results: In this report, we present a long-term follow-up (10 years) of a patient with GCT involving a metacarpal, who was initially reconstructed with a metacarpal head allograft, which was eventually revised to a metacarpophalangeal (MCP) total joint arthroplasty. Conclusions: To our knowledge, this is the only report of pyrocarbon being used for tumor reconstruction and the only report of late MCP allograft salvage.
Delaying Post-Operative Radiation in Low Grade Esthesioneuroblastoma: Is it Worth the Wait?
Agarwal, Vijay , Foote, Robert, Moore, Eric J. , Stokken, Janalee K., Janus, Jeffrey R. , Link, Michael J. , Hughes, Joshua , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | March 3, 2017 | Volume: 78 | Issue: S 01 | Pages: S1-S156

10.1055/s-0037-1600638 Get It

Extended Endoscopic Medial Maxillectomy and Removal of an Infratemporal Fossa Neurofibroma Presenting with Tinnitus and Aural Fullness
Moore, Eric J. , Stokken, Janalee K., Carlstrom, Lucas P. , Abel, Kathryn M. Van

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | March 3, 2017 | Volume: 78 | Issue: S 01 | Pages: S1-S156

10.1055/s-0037-1600762 Get It

Treatment and Outcomes of Reverse Shoulder Arthroplasty Dislocations
Sperling, John W. , Cofield, Robert H. , Chalmers, Brian P. , Wagner, Eric R. , Sánchez‐Sotelo, Joaquín

Mayo Clinic

Journal of Shoulder and Elbow Arthroplasty | March 1, 2017 | Volume: 1 | Issue: No issue available | Pages: No page available

10.1177/2471549217695260 Get It

Background Dislocation is a challenging complication after reverse shoulder arthroplasty (RSA). We sought to evaluate the outcome of nonoperative and operative management of the dislocation after primary and revision RSA. Methods Between 2006 and 2013, dislocation occurred in 12/1081 primary RSAs (1.1%) and 15/342 revision RSAs (4.4%). Seventeen (69%) shoulders dislocated within 3 months of surgery. Ten (68%) patients underwent revision RSA for prosthetic instability. Mean age was 69 years, and mean follow-up after index RSA was 4 years. Results Closed reduction and bracing achieved a stable shoulder in 60% (3/5 patients) after primary and 20% (1/5 patients) after revision RSA dislocation. Operative management achieved a stable shoulder in 88% (7/8 patients) of primary and 64% (7/11 patients) of revision RSAs ( P = .40). Overall, 9 shoulders (33%) had persistent instability at the final follow-up: 2/12 (17%) primaries versus 7/15 (47%) revisions ( P = .08). Preoperative prosthetic instability was the main risk factor for chronic instability in the revision cohort ( P = .02). Worse functional outcomes were associated with the dislocation of a revision RSA ( P = .02). Conclusion After primary RSA dislocations, closed reduction is successful in half, while revision surgery is successful in 85% of cases. Conversely, closed reduction of a dislocated revision RSA is rarely successful, while revision surgery is successful 65% of the time. Every attempt should be made to achieve stability at the time of primary and revision RSA, since reduction or revision surgery does not guarantee the restoring stability.
MR Imaging of Perianal Crohn Disease
Sheedy, Shannon P. , Bruining, David H. , Dozois, Eric J. , Faubion, William A. , Fletcher, Joel G.

Mayo Clinic

Radiology | February 28, 2017 | Volume: 282 | Issue: 3 | Pages: 628-645

10.1148/radiol.2016151491 | PMID 28218881 Get It